Evaluation of various treatments for carcinoma of the mandibular region

Br J Oral Maxillofac Surg. 1991 Aug;29(4):223-9. doi: 10.1016/0266-4356(91)90188-b.

Abstract

Cancers of the mandibular region show the lowest survival rates of all oral cancers. In order to compare the effect of five different modes of treatment (including surgery and/or radiotherapy), a series of 159 patients was analysed. When adjustments were made for age, sex and tumour stage in a log-linear multivariate analysis, no differences between treatments in the 5-year relative survival rates (RSR) could be demonstrated for stage I and II tumours. In stage III and IV tumours, radiation treatment alone resulted in poor survival. Between the other four treatments, all including surgery, no statistically significant differences in the 5-year relative survival rates were found. Radiation therapy as an element in combination therapy may have postponed a recurrence but did not affect the 5-year survival rate. For advanced tumours, mostly responsible for the low overall 5-year RSR, higher survival rates can possibly be achieved by improving surgical treatment of the primary lesion and the neck. At present, however, only earlier diagnosis might significantly increase the survival rates.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Squamous Cell / mortality
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / radiotherapy
  • Carcinoma, Squamous Cell / surgery
  • Carcinoma, Squamous Cell / therapy*
  • Combined Modality Therapy
  • Evaluation Studies as Topic
  • Female
  • Finland / epidemiology
  • Follow-Up Studies
  • Humans
  • Lymph Node Excision / statistics & numerical data
  • Male
  • Mandibular Neoplasms / mortality
  • Mandibular Neoplasms / pathology
  • Mandibular Neoplasms / radiotherapy
  • Mandibular Neoplasms / surgery
  • Mandibular Neoplasms / therapy*
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Neoplasm Staging
  • Radiotherapy Dosage
  • Retrospective Studies
  • Survival Rate
  • Time Factors